Atlas Trials

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Clinical trial NCT06156267 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06156267
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2024-01-01
Primary completion
2026-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.